Methylation-associated silencing of S100A4 expression in human epidermal cancers

Experimental Dermatology

Volumn 18, Issue 10, 2009, Pages 842-848

  Li, Yan ^a   Liu, Zhi Li ^a   Zhang, Kai Li ^a   Chen, Xiao Yan ^a   Kong, Qing You ^a   Wu, Mo Li ^a   Sun, Yuan ^a   Liu, Jia ^a   Li, Hong ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

DNA methylation; E cadherin; Epidermal cancer; Gene expression; S100A4; Skin; Wnt signalling

Indexed keywords

CALVASCULIN; UVOMORULIN; WNT PROTEIN;

ARTICLE; BOWEN DISEASE; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; DOWN REGULATION; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; PROTEIN EXPRESSION; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

AZACITIDINE; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BETA CATENIN; BIOPSY; CADHERINS; CELL LINE, TUMOR; DNA METHYLATION; DOWN-REGULATION; ENZYME INHIBITORS; EPIDERMIS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRONS; NEOPLASMS, GLANDULAR AND EPITHELIAL; S100 PROTEINS; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 70349871193     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.00922.x     Document Type: Article

References (46)

1. Sander CS, Chang H, Hamm F, et al. Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. Int J Dermatol 2004, 43:326-335.
2. Faurschou A, Haedersdal M, Poulsen T, et al. Squamous cell carcinoma induced by ultraviolet radiation originates from cells of the hair follicle in mice. Exp Dermatol 2007, 16:485-489.
3. Steward BW, Kleihues P. Reduction of Exposure to Ultraviolet Radiation 2003, 141-143. World Cancer Report, Lyon, France, IARC Press
4. Perrinaud A. Epidermoid (or squamous cell) carcinoma. Presse Med 2008, 37:1485-1489.
5. Helfman DM, Kim EJ, Lukanidin E, et al. The metastasis associated protein S100A4: role in tumor progression and metastasis. Br J Cancer 2005, 92:1955-1958.
6. Grigorian M, Andresen S, Tulchinsky E, et al. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 2001, 276:22699-22708.
7. Schafer BW, Heizmann CW. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 1996, 21:134-140.
8. Bjornland K, Winberg JO, Odegaard OT, et al. S100A4 involvement in metastasis: veregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti- S100A4 ribozyme. Cancer Res 1999, 59:4702-4708.
9. Ambartsumian N, Klingelhofer J, Grigorian M, et al. The metastasis-associated Mts1 (S100A4) protein could act as an angiogenic factor. Oncogene 2001, 20:4685-4695.
10. Levett D, Flecknell PA, Rudland PS, et al. Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancer. Am J Pathol 2002, 160:693-700.
11. Lloyd BH, Platt-Higgins A, Rudland PS, et al. Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells. Oncogene 1998, 17:465-473.
12. Davies BR, Davies MP, Gibbs FE, et al. Introduction of the metastatic phenotype of the transfection of a benign rat mammary epithelial cell line with the gene for p9ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene 1993, 8:999-1008.
13. Takenaga K, Nakamura Y, Sakiyama S. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high- metastatic Lewis lung carcinoma cells. Oncogene 1997, 14:331-337.
14. Gao XN, Tang SQ, Zhang XF. S100A4 antisense oligodeoxynucleotide suppresses invasive potential of neuroblastoma cells. J Pediatr Surg 2005, 40:648-652.
15. Grum-Schwensen B, Klingelhofer J, Berg CH, et al. Suppression of tumor development and metastasis formation in mice lacking the S100A4 gene. Cancer Res 2005, 65:3772-3780.
16. Zou M, Al Baradie RS, Al Hindi H, et al. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma. Br J Cancer 2005, 93:1277-1284.
17. Miyazaki N, Abe Y, Oida Y, et al. Poor outcome of patients with pulmonary adenocarcinoma showing decreased E-cadherin combined with increased S100A4 expression. Int J Oncol 2006, 28:1369-1374.
18. Mahon PC, Baril P, Bhakta V, et al. S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer. Cancer Res 2007, 67:6786-6795.
19. Hemandas AK, Salto-Tellez M, Maricar SH, et al. Metastasis-associated protein S100A4-a potential prognostic marker for colorectal cancer. J Surg Oncol 2006, 93:498-503.
20. Li Y, Zhang KL, Sun Y, et al. Frequent S100A4 expression with unique splicing pattern in gastric cancers: a hypomethylation event paralleled with e-cadherin reduction and wnt activation. Transl Oncol 2008, 4:165-176.
21. Ninomiya I, Ohta T, Fushida S, et al. Increased expression of S100A4 and its prognostic significance in esophageal squamous cell carcinoma. Int J Oncol 2001, 18:715-720.
22. Moriyama-Kita M, Endo Y, Yonemura Y, et al. S100A4 regulates E-cadherin expression in oral squamous cell carcinoma. Cancer Lett 2005, 230:211-218.
23. Martinsson H, Yhr M, Enerbäck C. Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation. Exp Dermatol 2005, 14:161-168.
24. Wolf R, Lewerenz V, Büchau AS, et al. Human S100A15 splice variants are differentially expressed in inflammatory skin diseases and regulated through Th1 cytokines and calcium. Exp Dermatol 2007, 16:685-691.
25. Uozumia M, Muraoa S, Katayama N, et al. Induction of S100A4 gene expression inhibits in vitro invasiveness of human squamous cell carcinoma, KOSC-3 cells. Cancer Lett 2000, 149:135-141.
26. Cheng X X, Sun Y, Chen XY, et al. Frequent translocalization of beta-catenin in gastric cancers and its relevance to tumor progression. Oncol Rep 2004, 11:1201-1207.
27. Moore GE, Merrick SB, Woods LK, et al. A human squamous cell carcinoma cell line. Cancer Res 1975, 35:2684-2688.
28. Boukamp P, Petrussevska RT, Bretkreutz D, et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988, 106:761-771.
29. Ebert MP, Fei G, Kahmann S, et al. Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 2002, 23:87-91.
30. Saleem M, Adhami VM, Ahmad N, et al. Prognostic significance of metastasis-associated protein S100A4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model. Clin Cancer Res 2005, 11:147-153.
31. Chen XY, Wang ZC, Li H, et al. Nuclear translocations of beta-catenin and TCF4 in gastric cancers correlate with lymph node metastasis but probably not with CD44 expression. Human Pathol 2005, 36:1294-1301.
32. Huang L, Zhang KL, Li H, et al. Infrequent COX-2 expression due to promoter hypermethylation in gastric cancers in Dalian, China. Human Pathol 2006, 37:1557-1567.
33. Zhang KL, Sun Y, Li Y, et al. Increased frequency of CpG island methylator phenotype and CDH1 methylation in a gastric cancer high-risk region of China. Transl Oncol 2008, 1:28-35.
34. Rehman I, Goodarzi A, Cross SS, et al. DNA methylation and immunohistochemical analysis of the S100A4 calcium binding protein in human prostate cancer. Prostate 2007, 67:341-347.
35. Xie R, Loose DS, Shipley GL, et al. Hypomethylation-induced expression of S100A4 in endometrial carcinoma. Mod Pathol 2007, 20:1045-1054.
36. Kohya N, Kitajima Y, Jiao W, et al. Effects of E-cadherin transfection on gene expression of a gallbladder carcinoma cell line: repression of MTS1/S100A4 gene expression. Int J Cancer 2003, 104:44-53.
37. Stein U, Arlt F, Walther W, et al. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. Gastroenterology 2006, 131:1486-1500.
38. Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004, 303:1483-1487.
39. Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg 2002, 28:268-273.
40. Andersen K, Nesland JM, Holm R, et al. Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma. Mod Pathol 2004, 17:990-997.
41. Situm M, Buljan M, Bulat V, et al. The role of UV radiation in the development of basal cell carcinoma. Coll Antropol 2008, 32:167-170.
42. Weinberg AS, Ogle CA, Shim EK. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg 2007, 33:599-885.
43. Rosty C, Ueki T, Argani P, et al. Overexpression of S100A4 in pancreatic ductal denocarcinomas is associated with poor differentiation and DNA hypomethylation. Am J Pathol 2002, 160:45-50.
44. Gontier E, Cario-André M, Vergnes P, et al. The role of E-cadherin in nevogenesis: an experimental study using epidermal reconstructs. Exp Dermatol 2004, 13:326-331.
45. Dokun OY, Florl AR, Seifert HH, et al. Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder can cer. Int J Cancer 2008, 123:2798-2807.
46. Bachman AN, Curtin GM, Doolittle DJ, et al. Altered methylation in gene-specific and GC-rich regions of DNA is progressive and nonrandom during promotion of skin tumorigenesis. Toxicol Sci 2006, 91:406-418.